Company profile: Mirati Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology, based at 9363 Towne Centre Dr, San Diego, CA, United States.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mirati Therapeutics
Diagnomics
HQ: United States
Website
- Description: Provider of NGS-based genomics solutions for personalized medicine and next-generation healthcare, offering high-quality R&D and CLIA services including whole genome, exome and RNA sequencing, microarray services, bioinformatics analysis, and clinical/translational research support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnomics company profile →
Multiplicom
HQ: Belgium
Website
- Description: Provider of molecular diagnostics products and clinical laboratory-based tests, including DNA/RNA library preparation and hybrid-capture target enrichment kits for Illumina sequencing. Offerings support low-input and FFPE samples, whole-genome and targeted sequencing, liquid biopsy applications, include molecular barcodes, and enable detection of low-frequency alleles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multiplicom company profile →
N-of-One
HQ: United States
Website
- Description: Provider of cancer care services that analyze and interpret tumor molecular profiles to help physicians and patients identify diagnostic and treatment strategies. Its clinicians and scientists collaborate with diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing, and conduct research to assess the standard of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N-of-One company profile →
Guide Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology solutions addressing delivery of genetic therapies, leveraging patented technologies to test thousands of chemically distinct nanoparticles in vivo to identify simple, scalable, clinically relevant nanoparticles that target new cell types efficiently and safely.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guide Therapeutics company profile →
Gateway Genomics
HQ: France
Website
- Description: Provider of genetically based tests for families and cancer care, including SneakPeek Early Gender Test to determine fetal sex from a small maternal blood sample as early as six weeks; Foresight Carrier Screen for inherited conditions; Prequel Prenatal Screen to identify risk of chromosomal conditions like Down syndrome from week 10; and oncology tests Prolaris and Precise to assess prostate cancer aggressiveness and tumor variants to guide treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gateway Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mirati Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mirati Therapeutics
2.2 - Growth funds investing in similar companies to Mirati Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mirati Therapeutics
4.2 - Public trading comparable groups for Mirati Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →